pegylated interferon alfa (Mountain View Pharmaceuticals)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namepegylated interferon alfa (Mountain View Pharmaceuticals)
Drug Alias Namepegylated interferon alpha (Mountain View Pharmaceuticals)PharmaPEG-interferon-alpha (Mountain View Pharmaceuticals)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInterferon alpha ligand
TargetsInterferon alpha
Therapy Area/IndicationsCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMountain View Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMountain View Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsCommunicable Diseases

Other Information

ATC CodeN/A
Related LinksN/A